The report says AIL's growth will be led by ramp-up in exclusive manufacturing and new capacity commissioning, with EBITDA/APAT 2/5% above estimates, and maintains ADD with a target price of INR 1,617.
Read this note →Aether Industries Limited
NSE AETHER BSE 543534 INE0BWX01014
0 filings · 0 analysed
1,590.10
+115.33%
over 1 year
-
HSIE Results Daily 31 Oct 26 HSIE
The report says AIL's growth will be led by ramp-up in exclusive manufacturing and new capacity commissioning, with EBITDA/APAT 2/5% above estimates, and maintains ADD with a target price of INR 1,617.
-
Aether Industries Update Oct26 HSIE
The report maintains an ADD rating on Aether Industries with a target price of INR 1,617, down from a prior target of INR 1,769, citing growth drivers including Magnum site ramp-up, new customer contracts, semiconductor platform build-out, and the Dow Chemicals silicone partnership.
-
Chemicals Q2FY27 Results Preview HSIE
The report expects revenue and EBITDA to grow over 22% YoY, aided by improved Baker Hughes contract revenue.
Prices from Yahoo Finance, NSE close, delayed — indicative only, not for dealing. Solid markers sit on the exchange's own timestamp.
Targets, and what happened next
What each house published, and where the price has gone since. Orivam issues no calls of its own and takes no view on these.
| House | Published | Call | Entry | Target | Now | Progress | Standing |
|---|---|---|---|---|---|---|---|
| HDFC Securities | 31 Oct 2026, 06:41 | long | 1,616.20 | 1,617.00 | 1,561.80 | -100% | open by 2027-10-31 |
| HDFC Securities | 14 Oct 2026, 15:45 | long | 1,682.60 | 1,769.00 | 1,561.80 | -100% | open by 2027-10-14 |
Deadlines: 0 stated by the house, the rest set by Orivam’s convention — ten trading days for a technical call, twelve months for a price target. A target with no date cannot be judged, so one has to be chosen.
What the desks said
The report maintains an ADD rating on Aether Industries with a target price of INR 1,617, down from a prior target of INR 1,769, citing growth drivers including Magnum site ramp-up, new customer contracts, semiconductor platform build-out, and the Dow Chemicals silicone partnership.
Read this note →The report expects revenue and EBITDA to grow over 22% YoY, aided by improved Baker Hughes contract revenue.
Read this note →Announcement timeline
No filings stored for this company yet.
Never miss the next one.
Orivam emails what the research desks published each trading morning, attributed and linked to the original notes. Free.
Get the daily brief